Molecular Partn N
MOLN
CHF
STOCK MARKET:
SWX
Open
 
...
Price in deferred time of 15 minutes
Last quote
06/14/2024 - 11:17:51
Bid
06/14/2024 - 11:21:14
Bid
Volume
Ask
06/14/2024 - 11:18:59
Ask
Volume
5.94
+0.64 ( +12.08% )
5.98
840
6.00
360
More information
Analysis by TheScreener
11.06.2024
Evaluation Slightly positive  
Interest Weak  
Sensibility Low  
Analysis date: 11.06.2024
Global Evaluation
  Slightly positive
The stock is classified in the slightly positive zone since 11.06.2024.
Interest
  Weak
Weak interest since 04.06.2024.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 03.05.2024 at a price of 3.40.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 04.06.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 3.440.
4wk Rel Perf
  35.68%
 
The four week relative overperformance versus STOXX600 is 35.68%.
Sensibility
  Low
The stock has been on the low-sensitivity level since 11.06.2024.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.75%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.59%.
Mkt Cap in $bn
  0.16
With a market capitalization <$2bn, MOLECULAR PARTNERS is considered a small-cap stock.
G/PE Ratio
  -3.81
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -1.75
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -6.66%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  24
For 1% of index variation, the stock varies on average by 0.24%.
Correlation
  0.06
Stock movements are totally independent of index variations.
Value at Risk
  0.54
The value at risk is estimated at CHF 0.54. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  12.08.2016